Galapagos Operating Margin from 2010 to 2024
| GLPG Stock | USD 27.31 0.18 0.66% |
Check Galapagos financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Galapagos' main balance sheet or income statement drivers, such as Depreciation And Amortization of 45.8 M, Interest Expense of 2.5 M or Selling General Administrative of 97.1 M, as well as many indicators such as Price To Sales Ratio of 7.86, Dividend Yield of 0.0 or PTB Ratio of 1.67. Galapagos financial statements analysis is a perfect complement when working with Galapagos Valuation or Volatility modules.
Galapagos | Operating Margin |
Latest Galapagos' Operating Margin Growth Pattern
Below is the plot of the Operating Profit Margin of Galapagos NV ADR over the last few years. It is Galapagos' Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Galapagos' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (0.91) % | 10 Years Trend |
|
Operating Profit Margin |
| Timeline |
Galapagos Operating Margin Regression Statistics
| Arithmetic Mean | (0.42) | |
| Geometric Mean | 0.32 | |
| Coefficient Of Variation | (139.04) | |
| Mean Deviation | 0.32 | |
| Median | (0.37) | |
| Standard Deviation | 0.58 | |
| Sample Variance | 0.33 | |
| Range | 2.699 | |
| R-Value | 0.07 | |
| Mean Square Error | 0.36 | |
| R-Squared | 0.01 | |
| Significance | 0.79 | |
| Slope | 0.01 | |
| Total Sum of Squares | 4.68 |
Galapagos Operating Margin History
About Galapagos Financial Statements
Galapagos stakeholders use historical fundamental indicators, such as Galapagos' Operating Margin, to determine how well the company is positioned to perform in the future. Although Galapagos investors may analyze each financial statement separately, they are all interrelated. For example, changes in Galapagos' assets and liabilities are reflected in the revenues and expenses on Galapagos' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Galapagos NV ADR. Please read more on our technical analysis and fundamental analysis pages.
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Galapagos NV was incorporated in 1999 and is headquartered in Mechelen, Belgium. Galapagos operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 1344 people.
Currently Active Assets on Macroaxis
When determining whether Galapagos NV ADR is a strong investment it is important to analyze Galapagos' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Galapagos' future performance. For an informed investment choice regarding Galapagos Stock, refer to the following important reports:Check out the analysis of Galapagos Correlation against competitors. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Galapagos. If investors know Galapagos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Galapagos listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.748 | Earnings Share (0.96) | Revenue Per Share 0.1977 | Quarterly Revenue Growth (0.50) | Return On Assets (0.02) |
The market value of Galapagos NV ADR is measured differently than its book value, which is the value of Galapagos that is recorded on the company's balance sheet. Investors also form their own opinion of Galapagos' value that differs from its market value or its book value, called intrinsic value, which is Galapagos' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Galapagos' market value can be influenced by many factors that don't directly affect Galapagos' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Galapagos' value and its price as these two are different measures arrived at by different means. Investors typically determine if Galapagos is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Galapagos' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.